About us
Medochemie is a global pharmaceutical company that develops, manufactures and commercializes Generics, with its Headquarters in Cyprus and a network of 21 subsidiaries in Europe and overseas. Employs over 1,700 highly skilled professionals, holds 4,500 marketing authorizations and owns 13 manufacturing sites in Cyprus, The Netherlands and Vietnam, designed to fully comply with European and WHO current Good Manufacturing Practices (cGMPs). The company operates for over 40 years bringing its therapies to patients in 107 countries around the globe with products that range between 10 therapeutic categories in oral, parenteral and topical presentations, including penicillins, cephalosporins and dry powder inhalers. We offer unique commercial expertise based on a global footprint by having established operations and long-term trusted partnerships in over 107 markets around the world. With our sustained investment in growing our pharmaceutical operations, we keep expanding our business network always with commitment and dedication to quality and safety. For more information, visit our website: www.medochemie.com
Specs about this supplier
| Sales markets | Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America |
|---|---|
| Affiliated categories: | Finished Dosage Forms More |
Products featured at CPhI Worldwide 2019
Event information
CPhI Worldwide 2019
5-7 November 2019 Frankfurt, Germany Visit us at stand 90B10Are you a supplier
Here's what we can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation